This inventor holds 1 USPTO granted patent. Top assignee: Cipla Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Siddharth Agrawal: Innovator in Pharmaceutical Compositions
Introduction
Siddharth Agrawal, an accomplished inventor based in Nagpur, India, has made significant contributions to the field of pharmaceuticals. His innovative approach has led to the development of a unique patent that holds promise for medical applications.
Latest Patents
Siddharth Agrawal holds a patent for pharmaceutical compositions that relate to the compound ((((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)oxy)methyl pivalate or its pharmaceutically acceptable derivatives. This invention may additionally incorporate various agents and outlines methods of their production and application in the medical field, showcasing his innovative prowess in pharmaceuticals.
Career Highlights
As a key member of Cipla Limited, Siddharth Agrawal has demonstrated his expertise in pharmaceutical research and development. His work at Cipla has allowed him to integrate scientific knowledge with practical applications in medicine, contributing to advancements that can improve patient care and treatment options.
Collaborations
In his innovative journey, Siddharth collaborates closely with Geena Malhotra, a fellow researcher at Cipla Limited. Together, they engage in thorough investigations aimed at developing effective pharmaceutical solutions that address critical health challenges.
Conclusion
Siddharth Agrawal stands out as a distinguished inventor in the realm of pharmaceutical compositions. His patent not only represents a significant advancement in medicine but also underscores the potential of collaborative efforts in innovation. As he continues to work with esteemed professionals like Geena Malhotra at Cipla Limited, the future looks bright for Siddharth and the innovations he brings forth.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
